Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation-Reference-Cited by-同舟云学术

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation

Published:2017-01 Issue:1 Volume:3 Page:1-6
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Liu Jonathan,Goicochea Pedro,Block Timothy,Brosgart Carol L.,Donaldson Eric F.,Lenz Oliver,Gee Lim Seng,Marins Ed G.,Mishra Poonam,Peters Marion G.,Miller Veronica

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference47 articles.

1. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature;Basnayake;J Viral Hepat,2016

2. Hepatitis B;Centers for Disease Control,2015

3. Estimating the global prevalence of hepatitis B;MacLachlan;Lancet,2015

4. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions;Viruses;2022-11-17

2. A Single and Multiple Ascending Dose Study of Toll‐Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers;Clinical and Translational Science;2020-05-14

3. Editorial;Current Opinion in HIV and AIDS;2020-05

4. Rhodium catalyzed stereospecific reductive carbocyclization of 1,6-enynes and synthesis of 4′-methyl-6′-substituted aristeromycins;Nucleosides, Nucleotides and Nucleic Acids;2019-01-28

5. Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs;Hepatology, Medicine and Policy;2018-01-05